Latest Boehringer Ingelheim Stories
VANCOUVER, British Columbia, March 31, 2015 /PRNewswire/ -- InMed Pharmaceuticals Inc.
- Nearly double the percentage of patients on BI 655066 with clear or almost clear skin (PASI 90) after 12 weeks vs.
-- Data show initial therapy in newly diagnosed NVAF patients diverged from guideline recommendations RIDGEFIELD, Conn., March 16, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals,
BOCA RATON, Fla., March 12, 2015 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for dabigatran etexilate
RANCHO CORDOVA, Calif., March 10, 2015 /PRNewswire/ -- AMPAC Fine Chemicals LLC (AFC) has announced that Don Whiteaker has joined AFC as Senior Director Supply Chain.
-- First BLA submission for an investigational reversal agent for a novel oral anticoagulant RIDGEFIELD, Conn., March 2, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
Active Pharmaceutical Ingredients (API) Market in the US 2015-2019 says the strong preference for generic drugs is the major market driver while and the strong focus on the high - potency API is the
- Less than 1 in 3 patients and caregivers are prepared for how IPF will affect their daily life RIDGEFIELD, Conn., Feb.
LONDON, February 10, 2015 /PRNewswire/ -- Report Details What are the commercial prospects for pharmaceutical [https://www.visiongain.com/Pharma/47/Reports
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.